Mobile Menu

News

Years

Categories

Media Inquiries

Sarah Corley

marketing@echo.global

405-753-4232

September 2, 2022

U.S. Economic Development Administration Awards $35 million Grant to the Oklahoma Biotech Innovation Cluster

Today, President Biden will announce the Oklahoma Biotech Innovation Cluster as one of 21 winners of the $1 billion Build Back Better Regional Challenge, the most impactful regional economic development competition in decades. Funded by President Biden’s American Rescue Plan and administered by the U.S. Department of Commerce’s Economic Development Administration (EDA), the Regional Challenge is awarding approximately $35 million in grants to the Oklahoma Biotech Innovation Cluster, led by the Oklahoma City Economic Development Foundation, to expand the biotechnology industry in the Oklahoma City region.

Read More

August 30, 2022

Zeno Technologies Helps Oil Companies Make Smarter Decisions

After noticing a relative lack of software investment in the oil and gas industry, Zeno Technologies has developed a data aggregation and analytics platform. It helps oil and gas companies analyze multiple operational scenarios through financial modeling with the goal of providing consistent returns to investors.

Read More

August 10, 2022

Zeno Celebrates Key Milestones in Customer Acquisition, Product Growth

Zeno Technologies, a pioneer in helping businesses master the financial performance of their energy assets, has achieved significant traction following the company’s public launch in October 2021. In just nine months since emerging from stealth, Zeno won key client engagements and expanded its product offering to help energy businesses exert better capital discipline to deliver predictable returns to their investors.

Read More

July 19, 2022

Deka Biosciences Breaks Ground on New Facility

Deka Biosciences announced today that it is breaking ground on a 14,000 square foot office and lab which will house a state of the art Research and Development, Process Development, and Manufacturing facility to further develop their novel cytokine therapies. This will be the first facility to house a dual targeted cytokine development lab in the DC/Maryland/Virginia region and the only company in the US developing a therapeutic of its kind. The new headquarters will be located at 20380 Seneca Meadows Parkway in Germantown, Maryland and Deka anticipates the move to be completed in the first quarter of 2023.

Read More

May 3, 2022

'We have to think differently.' OKC vies for $55M grant to grow biosciences industry

A group of Oklahoma City’s leading civic, bio-science and university players pitched a vision Monday on how they hope to work together to use a $55 million Economic Development Administration Grant to further build up the region’s growing innovation cluster.

Read More

Let’s build something great together.